Maravai LifeSciences Holdings, Inc. (MRVI)
After hours:
| Previous Close | 4.96 |
| Open | 5.00 |
| Bid | 5.18 x 1000 |
| Ask | 5.26 x 400 |
| Day's Range | 4.92 - 5.32 |
| 52 Week Range | 4.28 - 11.56 |
| Volume | |
| Avg. Volume | 1,793,346 |
| Market Cap | 1.318B |
| Beta (5Y Monthly) | 0.02 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.67 |
| Earnings Date | Feb 20, 2025 - Feb 24, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.73 |
Simply Wall St.Exploring ACNB And 2 More Undervalued Small Caps With Insider Buying In US
Over the last 7 days, the United States market has dropped by 1.2%, yet it has risen by an impressive 30% over the past year, with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying stocks that are perceived as undervalued and have insider buying can be a promising strategy for investors looking to capitalize on potential growth opportunities.
GlobeNewswireMaravai LifeSciences Announces November 2024 Investor Conference Schedule
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences in November. On November 19, 2024, at 8:30 a.m. PST/ 11:30 a.m. EST, Kevin Herde, Chief Financial Officer, and Drew Burch, President, Nucleic Acid Production, will participate in a fireside chat at the Stifel Healthcare Conference in New York, NY. On
